ATG7 and breast cancer: Moreover, orthotopic BC xenograft models confirmed that Alpelisib-resistant and ATG7-knockout cells are similarly susceptible to DCA and Metformin treatment in vivo whereas parental cells do not respond (Fig. 7b–e).